IACS Leadership
Associate Director, Oncogenomics
Alexei Protopopov, Ph.D.
Alexei Protopopov, Ph.D., joins MD Anderson after more than a decade of cancer genetics research at Dana-Farber Cancer Institute and Karolinska Institute, Stockholm, Sweden. During his career, he pioneered and implemented multiple methods of molecular cytogenetics, from fiber-FISH and SKY to microarrays and NextGen Sequencing. He developed new approaches for genomic and epigenetic characterization of tumors, specifically focusing on GEM models, tumor microenvironment and single cell genomics. His research resulted in more than 70 publications in peer-reviewed journals, including Nature and Science.
During his time at Dana-Farber, he led the Arthur and Rochelle Belfer Center for Cancer Genomics and served as a production manager/technical director of The Cancer Genome Atlas' Cancer Genome Characterization Center at Harvard Medical School.
Protopopov received his Ph.D. in biophysics (cell and molecular biology) with Professor Josef Gitelson at the Institute of Biophysics, Russia, trained in tumor biology and completed his post-doctoral research in the laboratory of Professor George Klein at Karolinska Institute, Sweden.
Institute Leadership
- Giulio Draetta, M.D., Ph.D. - Director
- Lynda Chin, M.D. - Scientific Director
- Carlo Toniatti, M.D., Ph.D. - Head of Research
- Philip Jones, Ph.D. - Head of Drug Discovery
- Eric Devroe, Ph.D. - Executive Director, Strategic Alliances
- Jannik Andersen, Ph.D. - Senior Associate Director, Drug Discovery Biology
- Joseph Marszalek, Ph.D. - Senior Associate Director, Target Validation
- Timothy Heffernan, Ph.D. - Associate Director, Target Discovery
- James Horner, B.S. - Associate Director, Mouse Cancer Models
- Ming-Kuei Jang, Ph.D., - Associate Director, Neurobiology
- Alexei Protopopov, Ph.D. - Associate Director, Oncogenomics
- Jianhua (John) Zhang, Ph.D. - Associate Director, Bioinformatics